Advanced Biomed is trading at $7.50 (6%) up after formally terminating its $25 million equity purchase agreement with Helena Global Investment Opportunities I Ltd., effective July 21, 2026.
- Traders are reacting to the reduced risk of future share dilution following the closure of the standby equity facility.
- The move extends a period of sharp volatility for the micro-cap stock as investors digest recent financing updates and strategic pivot news.